Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The present pilot study is aimed to obtain preliminary data on the effect of three ascending
oral dose levels of nepadutant on the relief of symptoms associated with feeding intolerance.
In addition, the assessment of drug exposure (PK assessment) will provide additional
information on the dose-effect relationship, thus supporting the dose selection and dosing
schedule in the future studies.